Group 1 - The core viewpoint of the news highlights the performance of the TaiKang Medical Health Fund, which saw declines in its two share classes, with Class C down by 13.45% and Class A down by 13.02% in 2025 [2][3] - The top ten holdings of the TaiKang Medical Health Fund in the third quarter of 2025 included companies such as JingTai Holdings, Kanglong Chemical, Fangzhou Jianke, SanSheng Pharmaceutical, Zhaoyan New Drug, Jiuan Medical, Yirui Technology, Lingrui Pharmaceutical, Baipusais, and Bid Medical [2] - The fund manager, Fu Hongzhe, has a background as a senior researcher at China Europe Fund Management Co., and has been with TaiKang since July 2019, becoming the fund manager on March 8, 2022 [2]

Group 1 - The core viewpoint of the news is that the Taikang Medical Health Fund has experienced significant declines in its stock performance for both Class C and Class A shares, with decreases of 13.45% and 13.02% respectively in 2025 [1][2] - The top ten holdings of the fund as of the third quarter of 2025 include companies such as Jingtai Holdings, Kanglong Chemical, Fangzhou Jianke, Sanofi Pharmaceutical, Zhaoyan New Drug, Jiuan Medical, Yirui Technology, Lingrui Pharmaceutical, Baipusais, and Bid Medical [1] - The fund manager, Fu Hongzhe, has a background as a senior researcher at China Europe Fund Management Co., Ltd. and has been with Taikang since July 2019, becoming the fund manager on March 8, 2022 [1]

Core Viewpoint - The report highlights a significant institutional ownership in the company, with a total of 14 institutional investors holding 3.94 billion shares, representing 51.87% of the total share capital as of August 25, 2025 [1] Group 1: Institutional Ownership - A total of 14 institutional investors disclosed their holdings in the company, with a combined shareholding of 3.94 billion shares, accounting for 51.87% of the total share capital [1] - The top ten institutional investors collectively hold 51.84% of the shares, with a decrease of 3.21 percentage points compared to the previous quarter [1] Group 2: Public Fund Holdings - Two public funds increased their holdings during this period, while three public funds reduced their holdings, with a decrease rate of 0.24% [2] - Four new public funds disclosed their holdings this period, while seven public funds were not disclosed compared to the previous quarter [2] Group 3: Insurance Capital Holdings - One insurance capital entity, China Life Insurance Co., Ltd., reported a slight decrease in holdings during this period [2]